
DD Stock Forecast & Price Target
DD Analyst Ratings
Bulls say
DuPont de Nemours has demonstrated robust organic sales growth in its Healthcare & Water business, attributed to strong demand in medical packaging, biopharma, and reverse osmosis, positioning it favorably in a lucrative market. The company's focused shift towards new products, as indicated by its vitality index improvement goals, suggests potential for enhanced price and mix dynamics, which could positively impact profitability in the coming years. Additionally, the Electronics & Industrial segment anticipates growth from advancements in technology and infrastructure, such as 5G and IoT, contributing to a favorable long-term outlook for DuPont's valuation as it undergoes a significant portfolio transformation.
Bears say
The financial outlook for DuPont de Nemours is challenged by anticipated delays in synergy realization stemming from the DowDuPont merger, which may hinder operational efficiency and growth potential. Additionally, persistent weakness in the electronics and construction markets is expected to adversely affect revenue generation in these key sectors. Lastly, the slow recovery in the Chinese market further compounds the difficulties the company faces, impacting overall profitability and market performance.
This aggregate rating is based on analysts' research of DuPont de Nemours and is not a guaranteed prediction by Public.com or investment advice.
DD Analyst Forecast & Price Prediction
Start investing in DD
Order type
Buy in
Order amount
Est. shares
0 shares